RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

摘要

The invention is a compound represented by Structural Formula (I):; ;or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).